<DOC>
	<DOCNO>NCT00061152</DOCNO>
	<brief_summary>The purpose study gain initial information tolerability feasibility high-concentration capsaicin patch treatment painful HIV-associated neuropathy , whether result HIV disease and/or antiretroviral drug exposure . The study also provide preliminary safety efficacy information .</brief_summary>
	<brief_title>Pilot Study High-Concentration Capsaicin Patches Treatment Painful HIV-Associated Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Between 18 75 year age . Documented evidence HIV1 infection . Painful HIVassociated neuropathy , whether result HIV disease and/or antiretroviral drug exposure , primary symptom pain , burn dysesthetic discomfort foot least 2 month prior Screening Visit . AND : Diminished ankle reflex ( compare knee ) absent ankle reflex , AND/OR Distal diminution either vibration sensation pain temperature sensation leg . Either neurotoxic antiretroviral ( i.e. , didanosine [ ddI ] , zalcitabine [ ddC ] , stavudine [ d4T ] ) exposure least 8 week prior Screening Visit , OR Currently stable dose ( ) neurotoxic antiretrovirals list least 8 week prior Screening Visit , without foreseeable need change dose medication duration study . Screening Pain Sum Score 12 36 . Intact , unbroken skin painful area ( ) treat . If take chronic pain medication , stable ( PRN ) regimen least 7 day prior Treatment Visit ( Day 0 ) willing maintain medication stable dose ( ) schedule throughout study . Be willing able use Roxicodone® ( oxycodone ) oral solution , need , relieve treatmentassociated discomfort . Female subject childbearing potential must negative urine serum pregnancy test , perform Screening Visit . All subject must willing use effective method birth control and/or refrain participate conception process study 30 day follow experimental drug exposure . Be willing able comply protocol requirement duration study participation . ( Such requirement include , limited : complete daily pain diary , attend study visit , refrain extensive travel study participation . ) Presence acute , active opportunistic infection , except oral thrush ; oral , genital , rectal herpes ; Mycobacterium avium bacteremia within 2 week prior Screening Visit . Significant pain etiology painful HIVassociated neuropathy , example , compressionrelated neuropathy , e.g. , spinal stenosis , fibromyalgia arthritis . Subjects must significant ongoing pain cause ( ) may interfere judge HIVassociated neuropathy pain . Evidence another contributing cause peripheral neuropathy , e.g. , diabetes mellitus , hereditary neuropathy , vitamin B12 deficiency ( B12 level less equal 200 pg/mL ) less 3 month B12 supplementation prior Screening Visit , treatment within 90 day prior Screening Visit drug may contribute sensory neuropathy . Any implanted medical device ( spinal cord stimulator , intrathecal pump peripheral nerve stimulator ) treatment neuropathic pain . Recent use ( within 21 day precede Treatment Visit [ Day 0 ] ) topically apply pain medication , nonsteroidal antiinflammatory drug , menthol , methyl salicylate , local anesthetic ( include Lidoderm® ) , steroid capsaicin product painful area . Treatment acute opportunistic infection within 14 day Treatment Visit ( Day 0 ) . Maintenance treatment cytomegalovirus ( CMV ) retinitis , Mycobacterium avium bacteremia , cryptococcal meningitis permit . Current use investigational drug , Class 1 antiarrhythmic drug ( tocainide mexiletine ) . Hypersensitivity capsaicin ( i.e. , chili pepper OTC capsaicin product ) , local anesthetic , Roxicodone adhesives . Significant ongoing untreated abnormality cardiac , renal , hepatic , pulmonary function may interfere either ability complete study evaluation adverse event . Currently active malignant disease . Malignancies remission require treatment Kaposi 's sarcoma require local treatment allow . High tolerance opioids preclude ability relieve treatmentassociated discomfort Roxicodone® need , judge investigator . History current problem prescription drug , illicit substance , alcohol abuse self report judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Pain Measurement</keyword>
	<keyword>Diary</keyword>
	<keyword>Painful HIV Neuropathy</keyword>
	<keyword>HIV Neuropathy</keyword>
	<keyword>Capsaicin</keyword>
	<keyword>Analgesics/*therapeutic use</keyword>
	<keyword>Capsaicin/*administration &amp; dosage/adverse effect</keyword>
	<keyword>Peripheral Nervous System Diseases/*complications/diagnosis/*therapy</keyword>
	<keyword>Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology</keyword>
	<keyword>Pain</keyword>
</DOC>